Risk of adverse outcomes during gabapentinoid therapy and factors associated with increased risk in UK primary care using the clinical practice research datalink: a cohort study.  Muller S, Bailey J, Bajpai R, Helliwell T, Harrisson SA, Whittl…

Direct-to-Consumer Educational Brochures to Promote Gabapentinoid Deprescribing in Older Adults.  Gingras M, Dubé R, Williams J, et al.  JAMA Intern Med. Published online September 23, 2024. doi:10.1001/jamainternmed.2024.4748 http…

Mechanism of gabapentinoid potentiation of opioid effects on cyclic AMP signaling in neuropathic pain.  Garza-Carbajal A, Bavencoffe A, Herrera JJ, Johnson KN, Walters ET, Dessauer CW.  Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2405…

Gabapentinoids increase the potency of fentanyl and heroin and decrease the potency of naloxone to antagonize fentanyl and heroin in rats discriminating fentanyl.  Hiranita T, Flynn SM, Grisham AK, Mijares AE, Murphy EN, France CP.  J Ph…

A. Risk of drug-related death associated with co-prescribing of gabapentinoids and Z-drugs among people receiving opioid-agonist treatment: A national retrospective cohort study.  Glancy M, Palmateer N, Yeung A, Hickman M, Macleod J, Bishop J…

Pregabalin-induced rhabdomyolysis: a case series and literature analysis.  Zhai W, Liu H, Li J, Xin H.  J Int Med Res. 2024 Jun;52(6):3000605241257776. doi: 10.1177/03000605241257776. PMID: 38879799; PMCID: PMC11181883. https://www.ncbi…